Alcohol use is widespread and alcohol use disorder (AUD) causes substantial harm. AUD affects 29 million individuals and ...

Alcohol use is widespread and alcohol use disorder (AUD) causes substantial harm. AUD affects 29 million individuals and causes more than 140,000 deaths annually in the U.S. alone. Individuals with ...

Axsome Therapeutics AXSM announced the initiation of the phase III study called FORWARD with the dosing of the first patient, ...

Jia’s team developed a protocol to improve the screening of protein pockets. This involved identifying the pockets, removing ...

The diabetic neuropathy market is poised for growth driven by clinical evidence, patient-centric care, digital health models, and innovative pharmacologic options. Key opportunities include enhancing ...

How the tobacco industry rebranded a brutally addictive drug from deadly to desirable—and what it means for our health.

Narcolepsy can lead to excessive daytime sleepiness, as well as cataplexy, a sudden loss of muscle tone. Other symptoms can include sleep paralysis and hallucinations that occur both during sleep ...

AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor being developed for the management of fibromyalgia. Esreboxetine is the SS-enantiomer of racemic reboxetine.

Oprah Winfrey has offered a striking explanation for her long battle with weight, arguing that obesity is not caused by ...

The tobacco industry rebranded a brutally addictive drug from deadly to desirable—and the longer-term health consequences may ...

Researchers from Denmark have uncovered strong evidence that depression often appears years before Parkinson’s disease and ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced ...